BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3492158)

  • 21. Identifying an apppropriate occupational exposure limit (OEL) for beryllium: data gaps and current research initiatives.
    Paustenbach DJ; Madl AK; Greene JF
    Appl Occup Environ Hyg; 2001 May; 16(5):527-38. PubMed ID: 11370933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic beryllium disease among dental technicians in Israel.
    Fireman E; Kramer MR; Priel I; Lerman Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Oct; 23(3):215-21. PubMed ID: 18038921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
    Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
    Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH
    Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occupational exposure to beryllium in French enterprises: a survey of airborne exposure and surface levels.
    Vincent R; Catani J; Créau Y; Frocaut AM; Good A; Goutet P; Hou A; Leray F; André-Lesage MA; Soyez A
    Ann Occup Hyg; 2009 Jun; 53(4):363-72. PubMed ID: 19372137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.
    Newman LS; Kreiss K; King TE; Seay S; Campbell PA
    Am Rev Respir Dis; 1989 Jun; 139(6):1479-86. PubMed ID: 2729754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beryllium exposure and chronic beryllium disease.
    Infante PF; Newman LS
    Lancet; 2004 Feb; 363(9407):415-6. PubMed ID: 14962519
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients.
    Müller-Quernheim J; Gaede KI; Fireman E; Zissel G
    Eur Respir J; 2006 Jun; 27(6):1190-5. PubMed ID: 16540500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A long-term follow-up of workers exposed to beryllium.
    Cotes JE; Gilson JC; McKerrow CB; Oldham PD
    Br J Ind Med; 1983 Feb; 40(1):13-21. PubMed ID: 6824594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.
    Newman LS; Mroz MM; Balkissoon R; Maier LA
    Am J Respir Crit Care Med; 2005 Jan; 171(1):54-60. PubMed ID: 15374840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A reconsideration of acute Beryllium disease.
    Cummings KJ; Stefaniak AB; Virji MA; Kreiss K
    Environ Health Perspect; 2009 Aug; 117(8):1250-6. PubMed ID: 19672405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an eight-hour occupational exposure limit for beryllium.
    Wambach PF; Tuggle RM
    Appl Occup Environ Hyg; 2000 Jul; 15(7):581-7. PubMed ID: 10893794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A canine model of beryllium-induced granulomatous lung disease.
    Haley PJ; Finch GL; Mewhinney JA; Harmsen AG; Hahn FF; Hoover MD; Muggenburg BA; Bice DE
    Lab Invest; 1989 Aug; 61(2):219-27. PubMed ID: 2755079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent chronic beryllium disease in residents surrounding a beryllium facility.
    Maier LA; Martyny JW; Liang J; Rossman MD
    Am J Respir Crit Care Med; 2008 May; 177(9):1012-7. PubMed ID: 18244954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.
    Kreiss K; Mroz MM; Zhen B; Wiedemann H; Barna B
    Occup Environ Med; 1997 Aug; 54(8):605-12. PubMed ID: 9326165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective beryllium exposure assessment at the Rocky Flats Environmental Technology Site.
    Barnard AE; Torma-Krajewski J; Viet SM
    Am Ind Hyg Assoc J; 1996 Sep; 57(9):804-8. PubMed ID: 8865588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease.
    Stefaniak AB; Hoover MD; Dickerson RM; Peterson EJ; Day GA; Breysse PN; Kent MS; Scripsick RC
    AIHA J (Fairfax, Va); 2003; 64(3):297-305. PubMed ID: 12809534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic beryllium disease in a dental laboratory technician.
    Kotloff RM; Richman PS; Greenacre JK; Rossman MD
    Am Rev Respir Dis; 1993 Jan; 147(1):205-7. PubMed ID: 8420418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of Metrics of Peak Inhalation Exposure and Skin Exposure Indices With Beryllium Sensitization at a Beryllium Manufacturing Facility.
    Virji MA; Schuler CR; Cox-Ganser J; Stanton ML; Kent MS; Kreiss K; Stefaniak AB
    Ann Work Expo Health; 2019 Oct; 63(8):856-869. PubMed ID: 31504146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.